Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
astrazeneca
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
covid-19
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
unity biotechnology
wisconsin blog main
wisconsin top stories
akouos
allergan
What
ceo
3
×
gilead
3
×
sciences
acquisitions
bio
covid
daniel
drug
o’day
roundup
addressed
announced
answers
big
biggest
build
buy
collabs
company’s
cost
deal
debut
dyne’s
early
gilead’s
hasten
help
indicated
introduce
ipo
medicine
medicines
microbiome
month
moves
openly
pipeline
plans
positive
question
Language
unset
Current search:
gilead
×
ceo
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@slashgear.com
3 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More